We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Watson Wants Lidoderm Suit Stayed For Ruling On FTC Power

Law360, Fort Wayne (February 16, 2017, 4:39 PM EST) -- Watson Laboratories Inc. asked a California federal court Wednesday to pause a renewed pay-for-delay lawsuit by the U.S. Federal Trade Commission over pain relief patch Lidoderm while a different court considers Watson's challenge to the agency’s authority to bring such a suit.

A Pennsylvania federal court is weighing Watson’s request for a ruling on the FTC’s authority to file suits over behavior that occurred in the past, the company said. The outcome of that case would weigh considerably on the agency’s California suit alleging Watson and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.